Specific Amplification of Rearranged Immunoglobulin Variable Region Genes from Mouse Hybridoma Cells
- 1 October 1990
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 9 (5) , 407-417
- https://doi.org/10.1089/hyb.1990.9.407
Abstract
In this article we show how the polymerase chain reaction (PCR) and primers designed for conserved sequences of leader (L), framework one (FR1) and constant (CONST) regions of immunoglobulin light and heavy chain genes can be used for the cloning and sequencing of rearranged antibody variable regions from mouse hybridoma cells. RNA was extracted from the mouse hybridoma cells secreting MAbs: IOR-T3a (anti-CD3), C6 (anti-P1 of N. meningitidis B385), IOR-T1 (anti-CD6), CB-CEA.1 (anti-carcinoembryonic antigen), and CB-Fib.1 (anti-human fibrin). First strand cDNA was synthesized and amplified using PCR. The newly designed primers are superior to others reported recently in the literature. Isolated PCR DNA fragments of C6 and IOR-T3a were sequenced after asymmetric amplification, or M13 cloning. The FR1/CONST primer combinations selectively amplified mouse lights chain of groups kappa II, V, and VI, and heavy chains of groups lla and llc. The L/CONST primers for light chains amplified light chains from all four hybridomas. These methods greatly facilitate structural and functional studies of antibodies by reducing the efforts required to clone and sequence their variable regions.This publication has 18 references indexed in Scilit:
- Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Proceedings of the National Academy of Sciences, 1989
- Genetically Engineered Antibody MoleculesPublished by Elsevier ,1989
- Human mAbs produced by primary in-vitro immunizationImmunology Today, 1988
- Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.The Journal of Immunology, 1988
- Reshaping human antibodies for therapyNature, 1988
- Novel antibody reagents: Production and potentialTrends in Biotechnology, 1988
- Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.Proceedings of the National Academy of Sciences, 1987
- Human immune response to multiple injections of murine monoclonal IgG.The Journal of Immunology, 1985
- The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primersGene, 1982
- Filamentous coliphage M13 as a cloning vehicle: insertion of a HindII fragment of the lac regulatory region in M13 replicative form in vitro.Proceedings of the National Academy of Sciences, 1977